TB/HIV 2019 symposium
A new era in TB prevention: Implications for people living with HIV
The International AIDS Society HIV Co-Infections and Co-Morbidities initiative convened the TB/HIV 2019 Symposium just prior to IAS 2019 in Mexico, as an event entirely devoted to research and implementation focused on TB prevention. The event was co-hosted by the International AIDS Society (IAS) in collaboration with the Stop TB Partnership and the United States Agency for International Development (USAID).
This symposium represented a unique opportunity to bring together a diversity of scientific, programmatic and community interests from of both the HIV and TB fields to share current knowledge on science of latent TB infection, as well as present and future opportunities and challenges in HIV-associated TB prevention. Sessions explored the latent TB infection, from the biology and immunology perspective, current and future treatment options and the policy and implementation perspectives to decrease the burden of TB in HIV programs, including programmatic approaches through primary health care and differentiated service delivery as crucial opportunities to reach global TB an HIV goals worldwide. Additional focus was given to the current and future developments of TB vaccines and the relevance and implications for high burden HIV settings.
The programme included a mixture of formats, such as focused thematic keynotes, a panel discussion, as well as an abstract driven poster exhibition, in addition to the views from the civil society. A final Call to action for a coordinated HIV and TB response to reach 6 million people living with HIV with tuberculosis preventive treatment aimed to galvanize global and national efforts to increase coverage and reach the new TB prevention goals globally.
Find the presentations, multimedia and more below.